Healthcare Realty Trust rporated(HR) - 2025 Q4 - Earnings Call Transcript

Financial Data and Key Metrics Changes - The company reported normalized FFO per share of $1.61 for the full year 2025, exceeding the midpoint of original guidance by $0.03 [10] - Same-store NOI growth was 4.8%, surpassing the midpoint of original guidance by 140 basis points [11] - In Q4 2025, normalized FFO per share was $0.40, with same-store cash NOI growth of 5.5% [23] Business Line Data and Key Metrics Changes - The company executed approximately 5.8 million square feet of leases in 2025, including 1.6 million square feet of new leases [15] - Tenant retention improved to 82% for the year, with same-store absorption translating to over 100 basis points of occupancy gain [15][16] - Cash leasing spreads improved by 60 basis points, and tenant retention increased by 220 basis points under the new asset management platform [8] Market Data and Key Metrics Changes - The outpatient medical transaction volume increased significantly in 2025, driven by rising patient and tenant demand alongside a lack of new supply [11] - Demand in the top 100 MSAs continues to outstrip supply, with completions as a percentage of inventory remaining near all-time lows [16] Company Strategy and Development Direction - The company aims to become the leader in the outpatient medical sector, focusing on driving long-term shareholder value through a three-year strategic plan [5][6] - Key initiatives include revamping the asset management platform, achieving G&A savings, and executing an ambitious asset disposition plan [7][8] - The company has successfully sold $1.2 billion of assets at a blended cap rate of 6.7%, exceeding expectations [9] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's premier outpatient medical portfolio, supported by nearly 5% same-store NOI growth in 2025 [9] - The outlook for 2026 includes normalized FFO guidance of $1.58-$1.64 per share, with same-store cash NOI growth expected to be 3.5%-4.5% [25] - Management acknowledged the need for disciplined capital allocation due to current cost of capital and discount to intrinsic asset value [11] Other Important Information - The company has reduced net debt to EBITDA to 5.4 times, improving financial flexibility and liquidity [9] - The dividend has been right-sized to be appropriate and well-covered, currently offering a nearly 6% yield [10] Q&A Session Summary Question: Same-store NOI guidance for 2026 - Management explained that the 3.5%-4.5% guidance reflects expectations for escalators, retention, absorption, and cash leasing spreads, with a focus on pushing these metrics [31][32] Question: CapEx relative to FAD for 2026 - Management indicated that if FFO is flat, FAD is also expected to be flat, with maintenance capital numbers provided in guidance [36][38] Question: Absorption potential and redevelopment leasing - Management confirmed that the absorption figures discussed were for the same-store pool, with expectations for significant contributions from redevelopment projects [40][42] Question: Acquisition potential and profile - Management stated that any acquisitions would be pursued only if they meet yield expectations, emphasizing discipline in capital allocation [44][46] Question: Dispositions going forward - Management outlined a plan for $175 million in sales for the year, with some deals expected to close early in 2026 [49][50]